Results to be shown provide evidence for common, remarkably homogeneous post-HSCT phenotypic patterns, for the expression of NKG2 ligands on the tumor and cognate immune receptors on the lymphoid graft, and for phenotypic/clinical outliers among patients undergoing allotransplantation as well as autotransplantation. The gene discussed is KLRC1; the disease is neoplasm.